Categories: HealthcareNews

Altruix Expands Behavioral Health Pharmacy Solutions to Virginia and Ohio

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Strategic Partnerships Increase Reach to 11 Locations Across 5 States

ANNAPOLIS, Md., Dec. 11, 2024 /PRNewswire/ — Altruix, a leading provider of behavioral health pharmacy solutions, continues its rapid growth, expanding into two new states and increasing its pharmacy network from 9 to 11 locations. Strategic partnerships in Virginia and Ohio are central to this expansion, addressing critical healthcare gaps and providing scalable, patient-centered solutions for high-demand markets.

Many individuals with behavioral health challenges face barriers to medication adherence, including costs and transportation. Altruix’s model addresses these issues by offering on-site pharmacies, flexible medication delivery options, and support in navigating the complexities of the healthcare system. Building on previous partnerships in Maryland, Pennsylvania and New Jersey, Altruix is offering a scalable solution that drives sustainable growth and long-term value.

“Our partnerships are driving our expansion into new regions, enabling us to deliver high-quality, accessible care where it’s needed most. As we continue to grow, we see exciting opportunities to scale our solutions and create long-term value for our partners, customers, and investors,” said Greg Ganse, CEO of Altruix.

Altruix continues to drive its mission forward by expanding access to tailored pharmacy services in high-need communities. “By partnering with mission-driven organizations in Ohio and Virginia, we’re advancing a proven model that enhances access to specialized pharmacy services and drives meaningful improvements in patient outcomes,” said Christy Rosado, President of Pharmacy Services at Altruix.

Altruix’s growth into new markets highlights the company’s success and sets the stage for continued expansion. As it continues to scale, Altruix is focused on driving sustainable impact while enhancing the health and well-being of underserved populations.

“As healthcare continues to prioritize value-based care, Altruix’s specialized expertise, coupled with its focus on removing barriers to medication access, positions the company as a leader in this space,” Ganse added.

For more information about Altruix and its services, visit https://altruix.com/.

About Altruix
Altruix is a behavioral health pharmacy dedicated to individuals with serious and persistent mental illness and intellectual & developmental disabilities. Altruix pharmacies serve this population through high-touch relationships with community-based behavioral health agencies, group homes, and other care providers. Altruix’s comprehensive suite of value-added pharmacy services and technology drives quantifiable improvements in medication adherence for the most complex behavioral health patients while easing the costly administrative burden for their caregivers. For more information, visit www.altruix.com.  

View original content to download multimedia:https://www.prnewswire.com/news-releases/altruix-expands-behavioral-health-pharmacy-solutions-to-virginia-and-ohio-302328133.html

SOURCE Altruix

Staff

Recent Posts

Hisense Unveils Latest AI-Driven Innovations at AWE 2025, Pioneering a New Era of Smart Living

DUBAI, UAE, March 27, 2025 /PRNewswire/ -- Hisense, a leading global consumer electronics brand showcased…

21 minutes ago

DeepCare Unveils Game-Changing Dental AI Agent at IDS 2025

COLOGNE, Germany, March 27, 2025 /PRNewswire/ -- From March 25 to 29, 2025, DeepCare, a global…

21 minutes ago

Ventra Health Launches Strategic Partnership with Radix Health to Offer Independent Dispute Resolution to Providers

DALLAS, March 26, 2025 /PRNewswire/ -- Ventra Health ("Ventra"), a leading business solutions provider for facility-based…

6 hours ago

Zepp Health Corporation Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

MILPITAS, Calif., March 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:…

12 hours ago

CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment

A global collaboration agreement has been signed for the development and commercialization of a Granzyme…

12 hours ago